Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $127716.0.

  • Cryo Cell International's Net Cash Flow rose 14699.62% to $127716.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $67770.0, marking a year-over-year increase of 11753.16%. This contributed to the annual value of $154893.0 for FY2024, which is 11193.42% up from last year.
  • According to the latest figures from Q3 2025, Cryo Cell International's Net Cash Flow is $127716.0, which was up 14699.62% from -$85631.0 recorded in Q2 2025.
  • Cryo Cell International's 5-year Net Cash Flow high stood at $916686.0 for Q1 2021, and its period low was -$6.1 million during Q1 2022.
  • Moreover, its 5-year median value for Net Cash Flow was -$177929.0 (2023), whereas its average is -$531364.1.
  • In the last 5 years, Cryo Cell International's Net Cash Flow plummeted by 8491258.28% in 2021 and then surged by 30430.79% in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's Net Cash Flow stood at $562282.0 in 2021, then tumbled by 317.1% to -$1.2 million in 2022, then soared by 85.42% to -$177929.0 in 2023, then surged by 304.31% to $363523.0 in 2024, then crashed by 64.87% to $127716.0 in 2025.
  • Its Net Cash Flow was $127716.0 in Q3 2025, compared to -$85631.0 in Q2 2025 and -$337838.0 in Q1 2025.